<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>1770821</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>García-Girón, C</dc:author>
<dc:author>Vicente Orta, J</dc:author>
<dc:author>Fernández de Castro, M</dc:author>
<dc:author>González Barón, M</dc:author>
<dc:author>Ordóñez Gallego, A</dc:author>
<dc:author>Burgos, E</dc:author>
<dc:author>Jiménez Herráez, C</dc:author>
<dc:description xml:lang="en">Myasthenia gravis (MG) and tricholeucemia (TL) produce an important immune alteration favoring the appearance of neoplastic and autoimmune disorders. The case of a 53 years old patient who developed type B TL 5 years after the diagnosis of MG is reported. Upon revision of the literature, 37 cases of association of MG and malignant hemopathies, fundamentally lymphoproliferative were found. In general, MG precedes the appearance of the neoplastic process. The autoimmunity and immunodeficiency characteristic of MG probably constitute the pathogenic mechanism leading to the appearance of the neoplastic process.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>1991 Nov 23 </dc:date>
<dc:title xml:lang="es">Asociación de miastenia grave y tricoleucemia.</dc:title>
<dc:title xml:lang="en">[The association of myasthenia gravis and hairy-cell leukemia].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
